The North American Viral Hepatitis Elimination Summit, a collaboration of the American Association for the Study of the Liver (AASLD), Canadian Association for the Study of the Liver (CASL), and Mexican Association of Hepatology (AMH) will be delivered on Tuesday March 18th, 2025, at the Global Hepatitis Summit in Los Angeles.
March 18th, 2025
10AM to 5PM
Objectives:
| Time | Session | Talk | Speakers |
| 10:00 | Opening | Introductions and Overview | Co-Chairs: Jordan Feld (CASL), Norah Terrault (AASLD), Sergio Muñoz (AMH) |
| Moderators: Jordan Feld, Norah Terrault / John Ward, Sergio Muñoz | |||
| 10:10 | NAVHES Session #1 | Taking Stock (profiles in NA): trends, progress towards targets and big scale initiatives | Moderators: John Ward & Carla Coffin |
| Canada – Canada’s STBBI Action Plan 2024-2030 | Mia Biondi (Canada) | ||
| Mexico – Expansion of HCV management in primary care | Alethse de la Rosas Torres (Mexico) | ||
| United States — US HCV elimination in transition | Risha Irvin (USA) | ||
| PANEL DISCUSSION: Includes patient representation (WHA, NVHR) | Richard So | ||
| 11:20 | NAVHES Session #2 | Diagnostics with the goal of increasing treatment | Moderators: Norah Terrault & Sergio Muñoz |
| HDV: reflex testing, status of anti-HDV & RNA testing in NA | Robert Gish (USA) | ||
| HBV testing – what needs to ∆ in policies & practice (qHBsAg, HBV POCT) | Carla Coffin (Canada) | ||
| HCV POCT and barriers to test & treat approach | Andrew Aronsohn (USA) | ||
| PANEL DISCUSSION | |||
| 12:25 | NAVHES Session #3 | Vaccination – an important cornerstone in Prevention | Moderators: John Ward & Carla Coffin |
| Elimination of HBV Transmission in an HBV Endemic Area in Western Alaska: Global Implications | Brian McMahon | ||
| HCV Vaccine trials in NA status report | Kim Page (USA) | ||
| 13:00 | Lunch Symposium | ||
| 14:05 | NAVHES Session #4 | Prevention Beyond Vaccination | Moderators: Jordan Feld & Graciela Castro |
| Next Steps in Elimination of MTCT of HBV and HCV in North America | Mia Biondi (Canada) | ||
| Liver cancer in VH in North America – surveillance challenges and solutions | Hashem El Serag (USA) | ||
| PANEL DISCUSSION: Includes session 3 speakers also | |||
| 15:10 | NAVHES Session #5 | Health equity: Delivering VH care in persons using drugs | Moderators: Norah Terrault & Sergio Muñoz |
| Prevention of HCV among PWID in Mexico | Fatima Higuera (Mexico) | ||
| PWIDs – novel programs in U.S. | Alain Litwin (USA) | ||
| Supervised injection sites and SSPs in Canada | Bernadette Lettner (Canada) | ||
| PANEL DISCUSSION: Includes patient representation (WHA) | Jessica Hicks | ||
| 16:15 | Wrap-up and Next Steps | Blueprint/Roadmap strategy | Moderators: John Ward, Norah Terrault, Jordan Feld & Sergio Muñoz |
Organizer
MCI Canada
555 Burrard St, 1st Floor,
Vancouver, BC, V7X 1M8
Canada
[email protected]
Book your stay now at preferential rates at The Westin Bonaventure Hotel & Suites, Los Angeles, the official venue for GHS 2025!
